Product Images Ocrevus
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Ocrevus NDC 50242-150 by Genentech, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - ocrevus 01
This text appears to be a mix of numerical values, medication names, and statistical data related to health outcomes. The medications mentioned are REBIF and EVUS, which may be used to treat conditions that have led to disability progression. The text also provides a percentage that notes a reduction in the risk of a particular health outcome, as well as a chart displaying the number of patients and their risk levels over time. However, the purpose and context of this information are unclear.*
Figure 2 - ocrevus 02
PRINCIPAL DISPLAY PANEL - 300 mg/10 mL Vial Carton - ocrevus 03
NDC 50242-150-01 is a medication called Ocrevus® (ocrelizumab). It is administered through intravenous infusion and comes in a single-dose vial that must be diluted. Any unused portion of the drug must be discarded. Pharmacists are advised to provide patients with the accompanying Medication Guide.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.